Skip to main content
Top

2024 | OriginalPaper | Hoofdstuk

57. Pityriasis rosea

Auteur : Rosalie Mensink-Bout

Gepubliceerd in: Kleine Kwalen in de huisartsenpraktijk

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Kernpunten

  • Pityriasis rosea is een schilferende, soms sterk jeukende huidaandoening, die vooral voorkomt bij adolescenten en jongvolwassenen.
  • Kenmerkend voor pityriasis rosea is een plaque mère, of tache mère, maar afwezigheid hiervan sluit de diagnose niet uit.
  • Pityriasis rosea geneest spontaan binnen 6–8 weken.
  • Koelzalf, lokale corticosteroïden of orale antihistaminica kunnen de jeuk verlichten.
Literatuur
1.
go back to reference Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol. 2009;61(2):303–18.CrossRefPubMed Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol. 2009;61(2):303–18.CrossRefPubMed
2.
go back to reference Villalon-Gomez JM. Pityriasis Rosea: Diagnosis and Treatment. Am Fam Physician. 2018;97(1):38–44.PubMed Villalon-Gomez JM. Pityriasis Rosea: Diagnosis and Treatment. Am Fam Physician. 2018;97(1):38–44.PubMed
4.
go back to reference Ciccarese G, Broccolo F, Rebora A, Parodi A, Drago F. Oropharyngeal lesions in pityriasis rosea. J Am Acad Dermatol. 2017;77(5):833–7.e4.CrossRefPubMed Ciccarese G, Broccolo F, Rebora A, Parodi A, Drago F. Oropharyngeal lesions in pityriasis rosea. J Am Acad Dermatol. 2017;77(5):833–7.e4.CrossRefPubMed
5.
go back to reference Contreras-Ruiz J, Peternel S, Jiménez Gutiérrez C, Culav-Koscak I, Reveiz L, Silbermann-Reynoso ML. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2019;2019(10):CD005068. Contreras-Ruiz J, Peternel S, Jiménez Gutiérrez C, Culav-Koscak I, Reveiz L, Silbermann-Reynoso ML. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2019;2019(10):CD005068.
6.
go back to reference Drago F, Ciccarese G, Herzum A, Rebora A, Parodi A. Pityriasis Rosea during pregnancy: major and minor alarming signs. Dermatology. 2018;234(1–2):31–6.CrossRefPubMed Drago F, Ciccarese G, Herzum A, Rebora A, Parodi A. Pityriasis Rosea during pregnancy: major and minor alarming signs. Dermatology. 2018;234(1–2):31–6.CrossRefPubMed
8.
go back to reference McMahon DE, Kovarik CL, Damsky W, Rosenbach M, Lipoff JB, Tyagi A, et al. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. J Am Acad Dermatol. 2022;86(1):113–21.CrossRefPubMed McMahon DE, Kovarik CL, Damsky W, Rosenbach M, Lipoff JB, Tyagi A, et al. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. J Am Acad Dermatol. 2022;86(1):113–21.CrossRefPubMed
10.
go back to reference Chuh A, Zawar V, Sciallis G, Kempf W. A position statement on the management of patients with pityriasis rosea. J Eur Acad Dermatol Venereol. 2016;30(10):1670–81.CrossRefPubMed Chuh A, Zawar V, Sciallis G, Kempf W. A position statement on the management of patients with pityriasis rosea. J Eur Acad Dermatol Venereol. 2016;30(10):1670–81.CrossRefPubMed
Metagegevens
Titel
Pityriasis rosea
Auteur
Rosalie Mensink-Bout
Copyright
2024
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2962-5_57